Changes in the insulin-like growth factor-system may contribute to in vitro age-related impaired osteoblast functions

Ankersen, 1994, Aging of human trabecular osteoblasts in culture, Arch. Gerontol. Geriatr., 4, 5, 10.1016/S0167-4943(05)80042-1 Bagi, 1994, Benefit of systemically administered rhIGF-I and rhIGF-I/IGFBP-3 on cancellous bone in ovariectomized rats, J. Bone Miner. Res., 9, 1301, 10.1002/jbmr.5650090820 Barton-Davis, 1998, Viral mediated expression of insulin-like growth factor I blocks the aging-related loss of skeletal muscle function, Proc. Natl. Acad. Sci., USA, 95, 15 603, 10.1073/pnas.95.26.15603 Bennett, 1984, Insulin-like growth factors I and II: aging and bone density in women, J. Clin. Endocrinol. Metab., 59, 701, 10.1210/jcem-59-4-701 Boonen, 1996, Relationship between baseline insulin-like growth factor-I (IGF-I) and femoral bone density in women aged over 70years: potential implications for the prevention of age-related bone loss, J. Am. Geriatr. Soc., 44, 1301, 10.1111/j.1532-5415.1996.tb01399.x Brockstedt, 1993, Age- and sex-related changes in iliac cortical bone mass and remodeling, Bone, 14, 681, 10.1016/8756-3282(93)90092-O Campisi, 1996, Replicative senescence: an old lives’ tale?, Cell, 84, 497, 10.1016/S0092-8674(00)81023-5 Centrella, 1990, Receptors for insulin-like growth factors-I and -II in osteoblast- enriched cultures from fetal rat bone, Endocrinology, 126, 39, 10.1210/endo-126-1-39 Chelly, 1994, RT-PCR and mRNA quantitation, 97 Cohen-Solal, 1991, A new method for measuring cancellous bone erosion depth: application to the cellular mechanisms of bone loss in postmenopausal osteoporosis, J. Bone Miner. Res., 6, 1331, 10.1002/jbmr.5650061210 Conover, 1996, The role of insulin-like growth factors and binding proteins in bone cell biology, 607 Conover, 1993, Posttranslational regulation of insulin-like growth factor binding protein-4 in normal and transformed human fibroblasts. Insulin-like growth factor dependence and biological studies, J. Clin. Investig., 91, 1129, 10.1172/JCI116272 Davis, 1986 Ferber, 1993, Failure of senescent human fibroblasts to express the insulin-like growth factor-1 gene, J. Biol. Chem., 268, 17883, 10.1016/S0021-9258(17)46787-1 Grigoriev, 1995, Overexpression of insulin-like growth factor binding protein-3 by senescent human fibroblasts: attenuation of the mitogenic response to IGF-I, Exp. Cell Res., 219, 315, 10.1006/excr.1995.1234 Hassager, 1992, Basal and regulated secretion of insulin-like growth factor binding proteins in osteoblast-like cells is cell line specific, J. Clin Endocrinol. Metab., 75, 228 Janssen, 1998, Gender-specific relationship between serum free and total IGF-I and bone mineral density in elderly men and women, Eur. J. Endocrinol., 138, 627, 10.1530/eje.0.1380627 Johansson, 1997, Reduced serum levels of the growth hormone-dependent insulin-like growth factor binding protein and a negative bone balance at the level of individual remodeling units in idiopathic osteoporosis in men, J. Clin Endocrinol. Metab., 82, 2795 Kanzaki, 1994, Evidence that human bone cells in culture produce insulin-like growth factor-binding protein-4 and -5 proteases, Endocrinology, 134, 383, 10.1210/endo.134.1.7506211 Kassem, 1994, No evidence for reduced spontaneous or growth-hormone-stimulated serum levels of insulin-like growth factor (IGF)-I, IGF-II or IGF binding protein 3 in women with spinal osteoporosis, Eur. J. Endocrinol., 131, 150, 10.1530/eje.0.1310150 Kassem, 1996, Potential mechanism of estrogen-mediated decrease in bone formation: estrogen increases production of inhibitory insulin-like growth factor-binding protein-4, Proc. Assoc. Am. Physicians, 108, 155 Kassem, 1997, Demonstration of cellular aging and senescence in serially passaged long-term cultures of human trabecular osteoblasts, Osteoporos Int., 7, 514, 10.1007/BF02652556 Kassem, 1998, Estrogen effects on insulin-like growth factor gene expression in a human osteoblastic cell line with high levels of estrogen receptor, Calcif. Tissue Int., 62, 60, 10.1007/s002239900395 Kurland, 1997, Insulin-like growth factor-I in men with idiopathic osteoporosis, J. Clin. Endocrinol. Metab., 82, 2799 Kveiborg, 1999, Telomere shortening during aging of human osteoblasts in vitro and leukocytes in vivo: lack of excessive telomere loss in osteoporotic patients, Mech. Ageing Dev., 106, 261, 10.1016/S0047-6374(98)00114-6 Lamson, 1991, A simple assay for proteolysis of IGFBP-3, J. Clin. Endocrinol. Metab., 72, 1391, 10.1210/jcem-72-6-1391 Langlois, 1998, Association between insulin-like growth factor I and bone mineral density in older women and men: the Framingham Heart Study, J. Clin. Endocrinol. Metab., 83, 4257 Lawrence, 1999, The insulin-like growth factor (IGF)-dependent IGF binding protein-4 protease secreted by human fibroblasts is pregnancy-associated plasma protein-A, Proc. Natl. Acad. Sci., USA, 96, 3149, 10.1073/pnas.96.6.3149 Liang, 1992, Impaired bone activity in aged rats: alterations at the cellular and molecular levels, Bone, 13, 435, 10.1016/8756-3282(92)90087-D Middleton, 1995, Osteoblasts and osteoclasts in adult human osteophyte tissue express the mRNAs for insulin-like growth factors I and II and the type 1 IGF receptor, Bone, 16, 287, 10.1016/8756-3282(94)00040-9 Mohan, 1995, Age-related changes in IGFBP-4 and IGFBP-5 levels in human serum and bone: implications for bone loss with aging, Prog. Growth Factor Res., 6, 465, 10.1016/0955-2235(95)00027-5 Mohan, 1995, Studies on the mechanisms by which insulin-like growth factor (IGF) binding protein-4 (IGFBP-4) and IGFBP-5 modulate IGF actions in bone cells, J. Biol. Chem., 270, 20 424, 10.1074/jbc.270.35.20424 Nicolas, 1995, An age-related decrease in the concentration of insulin-like growth factor binding protein-5 in human cortical bone, Calcif. Tissue Int., 57, 206, 10.1007/BF00310260 Okazaki, 1994, Glucocorticoid regulation of insulin-like growth factor-binding protein expression in normal human osteoblast-like cells, Endocrinology, 134, 126, 10.1210/endo.134.1.7506203 Pfeilschifter, 1998, Relationship between IGF-I and skeletal aging, Eur. J. Endocrinol., 138, 617, 10.1530/eje.0.1380617 Qin, 1997, Double-monoclonal immunofluorometric assays for pregnancy-associated plasma protein A/proeosinophil major basic protein (PAPP-A/proMBP) complex in first-trimester maternal serum screening for Down syndrome, Clin. Chem., 43, 2323, 10.1093/clinchem/43.12.2323 Quarto, 1995, Bone progenitor cell deficits and the age-associated decline in bone repair capacity, Calcif. Tissue Int., 56, 123, 10.1007/BF00296343 Rajaram, 1997, Insulin-like growth factor-binding proteins in serum and other biological fluids: regulation and functions, Endocrinol. Rev., 18, 801 Rattan, 1995, Ageing—a biological perspective, Mol. Aspects Med., 16, 439, 10.1016/0098-2997(95)00005-2 Rosen, 1997, Growth hormone/insulin-like growth factor-I axis in aging: a summary of a National Institutes of Aging-sponsored symposium, J. Clin. Endocrinol. Metab., 82, 3919 Sambruk, 1989 Scharla, 1991, 25-Dihydroxyvitamin D3 differentially regulates the production of insulin-like growth factor I (IGF-I) and IGF-binding protein-4 in mouse osteoblasts, Endocrinology, 129, 3139, 10.1210/endo-129-6-3139 Seck, 1998, Concentration of insulin-like growth factor (IGF)-I and -II in iliac crest bone matrix from pre- and postmenopausal women: relationship to age, menopause, bone turnover, bone volume, and circulating IGFs, J. Clin. Endocrinol. Metab., 83, 2331 Sugimoto, 1997, Serum levels of insulin-like growth factor (IGF) I, IGF-binding protein (IGFBP)-2, and IGFBP-3 in osteoporotic patients with and without spinal fractures, J. Bone Miner. Res., 12, 1272, 10.1359/jbmr.1997.12.8.1272 Wergedal, 1990, Skeletal growth factor and other growth factors known to be present in bone matrix stimulate proliferation and protein synthesis in human bone cells, J. Bone Miner. Res., 5, 179, 10.1002/jbmr.5650050212